Are certain vaccines more effective than others?

Data collected during the use of the vaccines during the response supports the high effectiveness rates of all three vaccines in clinical trials. To learn more, visit here. 

To measure how well a vaccine works in a clinical trial, the Food and Drug Administration (FDA) first looks at the number of people who fell ill with the disease. Then the agency compares whether they received the vaccine or the placebo (a harmless, inactive substance that looks identical to the vaccine being tested). If a greater share of those who are sick received the placebo instead of the vaccine, then the vaccine has met an acceptable efficacy standard.

Learn more about this process here.

Covid-19 vaccines currently authorized in the United States demonstrated extremely high efficacy in clinical trials. The Pfizer and Moderna vaccines had efficacy rates of 95 percent and 94.1 percent, respectively. The Johnson & Johnson vaccine, meanwhile,  was 85 percent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination.

Bottom Line: People should accept the first vaccine that becomes available to them in their area.

Related Questions
Will I need a vaccine booster shot? If so, when can I get it?
Likely. The Centers for Disease Control and Prevention (CDC) is currently discussing the need for booster shots in individuals already vaccinated against COVID-19. The CDC is reviewing plans to roll out booster shots for the Pfizer-BioNTech and Moderna vaccines this fall to help people remain as protected as possible against new COVID variants. According to the CDC website, people may be eligible 8 months after receiving their second dose of the Pfizer-BioNTech or Moderna vaccines. The CDC is…
How dangerous is the Delta variant?
The Delta variant is the most contagious variant of COVID-19 to date, fueling new outbreaks in the United States and worldwide. This variant spreads twice as fast as other variants (read more about how viruses mutate here). Unvaccinated people are especially at risk of contracting Delta. According to at least two studies, patients infected with Delta had higher rates of hospitalizations than those who were infected with other COVID-19 strains. Unvaccinated people are far more…
Will the vaccine protect me against the Delta variant?
Yes – current vaccines provide at least some protection against the Delta variant. According to multiple studies (outlined here), the protection against Delta varies among vaccines. The studies estimate that the J&J vaccine is more than 67% effective, Moderna between 72 and 95% effective, and Pfizer-BioNTech between 42 and 96% effective. In addition to protecting people from contracting new variants, the vaccine is shown to reduce severity of infections and shorten recovery time. Most…